BioSpace News Archive

Danaher Corporation announced results for the third quarter 2019.

BriaCell Therapeutics Corp. announced that the shareholders approved all matters addressed at the special meeting of the holders of common shares in the capital of BriaCell held on October 22, 2019.

Retailer offers in-store kiosks at each of its 246 supercenter pharmacies, making it easier for customers to clean out medicine cabinets this weekend

Athenex, Inc. announced that it will release third quarter and nine-months ended September 30, 2019 financial results on Thursday, November 7, 2019, before the market opens, and host a conference call and live audio webcast 8:00am Eastern Time to discuss the financial results and provide a business update.

Sonde Health Inc., a leading company developing a voice-based technology platform to measure health when a person speaks, announced that David Liu has joined Sonde as chief executive officer and a member of its board of directors.

Educational Event to Feature Presentations from MRIdian® Users and ESTRO Past President on the Strategic, Economic, Clinical and Technical Aspects of MRI-Guided Radiation Therapy

Achieve Life Sciences, Inc. announced that data from the Phase 2b ORCA-1 trial will be presented at the SRNT-O Inaugural Conference.

A medication currently used to treat insomnia may also be effective in preventing alcohol intake and relapse in alcohol use disorder, according to researchers at the Florey Institute of Neuroscience and Mental Health.

CureVac AG, a clinical stage biopharmaceutical company pioneering the field of mRNA-based drugs, announced that it will participate in the Society for Immunotherapy of Cancer conference 2019 in National Harbor, Maryland, from November 6-10.

Athenex, Inc., a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related conditions, provides an update to its shareholders.